A strategy to boost the immune response to vaccination in patients with seropositive rheumatoid arthritis.
What’s new: advances in serodiagnostic testing, role of T cell activation in Lyme arthritis, and post-treatment Lyme disease syndrome.
Post-treatment Lyme disease syndrome is a real disorder with real symptoms, say researchers.
Tumor necrosis factor inhibitors and high-dose corticosteroids were the culprits.
MicroRNA collected in patients’ synovial fluid after treatment with antibiotics resembles that seen in chronic inflammatory states.
An increased risk of cardiovascular disease is present in early rheumatoid arthritis and early spondyloarthritis, new research shows.
In the non-rheumatology journals: Yet more promise for interferon-free treatment of hepatitis C. Also, stem cells and meniscectomy, and more insights into the link between scleroderma and cancer.
We routinely treat disorders such as rheumatoid arthritis, lupus, scleroderma, and ankylosing spondylitis with immunosuppressive drugs. Yet if infection were known to be the root cause, this course of action would seem counterintuitive, if not potentially dangerous in the short or long run.